A nurse is preparing to administer diphenhydramine to a client who is to receive a blood transfusion. The nurse should explain that the purpose diphenhydramine is to prevent which of the following manifestations of a transfusion reaction?

A. Family history: Having a family history of peptic ulcers increases the risk of developing the condition, suggesting a genetic predisposition.

B. Blood type A: There is no direct association between blood type A and peptic ulcer disease.

C. Acetaminophen (Tylenol) intake for pain: Acetaminophen is generally considered safe for pain relief and is not a significant risk factor for peptic ulcer disease. However, nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin, ibuprofen, and naproxen are known to increase the risk of peptic ulcers.

D. Smoking tobacco: Smoking tobacco is a significant risk factor for peptic ulcer disease. Tobacco use increases stomach acid production, weakens the protective lining of the stomach and duodenum, and impairs the healing of ulcers.

E. Drinking caffeine: While caffeine consumption alone may not directly cause peptic ulcers, excessive intake of caffeinated beverages such as coffee, tea, and soda can aggravate existing ulcers by stimulating stomach acid production and increasing gastric acidity.

A. Respiratory rate and pulse: Albuterol is a bronchodilator medication commonly used to relieve bronchospasm in conditions like asthma and chronic obstructive pulmonary disease (COPD). Monitoring the patient's respiratory rate and pulse is essential to assess the response to the medication and any potential adverse effects.

B. Pulse oximetry: Albuterol helps to open the airways and improve oxygenation in patients with bronchospasm. Monitoring oxygen saturation using pulse oximetry provides valuable information about the patient's respiratory status and response to treatment.

C. Capillary refill: Capillary refill is typically assessed to evaluate peripheral perfusion and circulation. While it is an important assessment in certain clinical situations, it is not directly related to monitoring the response to albuterol administration.

D. Glucose: Glucose monitoring is not typically indicated after administering albuterol nebulizer unless the patient has a history of diabetes or there are specific concerns regarding glucose levels.

E. Lung sounds: Assessing lung sounds before and after administering albuterol helps to evaluate the effectiveness of the medication in relieving bronchospasm. Improvement in lung sounds, such as decreased wheezing or clearer breath sounds, indicates a positive response to treatment.